HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Forum focuses on challenges facing women, girls affected by HIV in Eastern Europe, Central Asia

"Women, girls and HIV were the focus of a panel discussion on the final day of the International Forum on Millennium Development Goal (MDG) 6 in Eastern Europe and Central Asia," UNAIDS reports.

15 Oct 2011

Health groups urge Secretary of U.S. Army to sustain funding for military HIV research program

"Speaking out against a potential $16 million cut in the Army's base research and development budget for HIV, leaders of the Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA) sent a letter Thursday to the Secretary of the U.S. Army, John McHugh, making the case for sustaining the U.S. Military HIV Research Program (MHRP)," according to the Center for Global Health Policy's "Science Speaks" blog.

15 Oct 2011

Emergency grant to end U.S. AIDS drug crisis gets rejected

The Global Fund for AIDS, Tuberculosis and Malaria has notified the AIDS Healthcare Foundation (AHF) that an application it submitted on behalf of the United States for an emergency grant of $50 million to end the ongoing AIDS drug crisis in the U.S. is being rejected because, as one of the wealthiest nations in the world, "the United States is not eligible for funding from the Global Fund."

14 Oct 2011

USAID award supports study of SILCS diaphragm plus tenofovir gel on HIV, HSV

USAID awarded CONRAD a five year project with a $2 million ceiling to focus on testing the safety and effectiveness of the SILCS diaphragm, the one-size-fits-most contraceptive barrier, combined with tenofovir gel -- the only topical product proven to prevent the acquisition of HIV and Herpes Simplex Virus.

14 Oct 2011

Nature publishes Sangamo's gene correction strategy for A1AT deficiency

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the publication of a preclinical study demonstrating highly specific, functional correction of the alpha 1-antitrypsin (A1AT) gene defect in patient-derived induced pluripotent stem cells (iPSCs) using zinc finger nucleases.

14 Oct 2011

Merck announces results from ISENTRESS Phase III combination study on HIV-1

Merck, known as MSD outside the United States and Canada, today announced results of new exploratory pre-specified analyses from the ongoing STARTMRK Phase III study of its integrase inhibitor ISENTRESS (raltegravir) Tablets in combination therapy compared to efavirenz in combination therapy in previously untreated adult HIV-1-infected patients.

14 Oct 2011

Insight into how powerful anti-HIV antibody grabs hold of the virus

Researchers at The Scripps Research Institute have uncovered the surprising details of how a powerful anti-HIV antibody grabs hold of the virus. The findings, published in Science Express on October 13, 2011, highlight a major vulnerability of HIV and suggest a new target for vaccine development.

14 Oct 2011

Dual drug sneaks across the blood-brain barrier to fight HIV

In an advance toward eliminating pockets of infection in the brain that help make HIV disease incurable, scientists report the development of new substances that first plug the biological vacuum cleaner that prevents anti-HIV drugs from reaching the brain and then revert to an active drug to treat HIV.

14 Oct 2011

InnaVirVax announces Phase I/IIa clinical trial authorization for its VAC-3S HIV vaccine

InnaVirVax, a biopharmaceutical company dedicated to the development of therapeutic and diagnostic solutions in pathologies associated with immune dysregulation, declared today that it has obtained authorization from the French drug agency (AFSSAPS) to start a Phase I/IIa clinical study of its therapeutic vaccine VAC-3S for the treatment of HIV infections. This authorization intervenes only two years and half after the launching of InnaVirVax’s activities.

14 Oct 2011

Viewpoints: 'Moneyball' and health care; Daschle on diabetes treatment; Elton John and Sen. Nelson on paying for AIDS drugs

Billy Beane's data-driven strategies made him the talk of baseball, the king of the current box office and a highly visible advocate for evidence-based medicine. But Beane's teams have faded since their "Moneyball" heyday - and evidence-based medicine might not be the home run that some reformers hope it will be.

14 Oct 2011

Hydromorphone can be as effective as diacetylmorphine in treating heroin addiction

A clinical trial to test better treatment options for chronic heroin addiction is expected to begin in Vancouver at the end of this year. Led by researchers from Providence Health Care and the University of British Columbia, it's the only clinical trial of its kind in North America.

13 Oct 2011

Mental health services are 'critical' to comprehensive approach for people living with HIV

In this post in USAID's "IMPACTblog," Melissa Sharer, AIDSTAR-One senior care and support officer at John Snow, Inc., writes, "Although treatment is now widely available and people living with HIV (PLHIV) are able to live normal and active lives for many years, their mental health needs are often overlooked in care, treatment, and support programs." Sharer highlights the success of programs in Vietnam and in Uganda that "combine mental health and existing health services."

13 Oct 2011

U.S. Ambassador advises Kenya to seek additional sources of funding for health programs

"U.S. Ambassador Jonathan Gration has advised Kenya to seek new sources of money to finance health programs," Kenya's the Star reports, adding, "Gration said projects initiated by donors will only be sustainable if the Kenyan government takes over."

13 Oct 2011

VOA News examines how a public-private partnership will combat cancer among women in the developing world

This VOA News editorial examines how a public-private partnership between PEPFAR, the George W. Bush Institute, Susan G. Komen for the Cure, the Joint United Nations Programme on HIV/AIDS, as well as private sector partners will launch a program called Pink Ribbon, Red Ribbon to "combat cervical and breast cancer for women in sub-Saharan Africa and Latin America."

13 Oct 2011

Smoking could cause 18M more cases of TB worldwide over next 40 years

Smoking could cause 18 million more cases of tuberculosis worldwide over the next 40 years and 40 million additional deaths.

12 Oct 2011

India's Aurobindo Pharma first major generic drugmaker to Join UNITAID's Medicines Patent Pool

"India's Aurobindo Pharma has become the first major generic drugmaker to join" the Medicines Patent Pool, launched by the UNITAID health financing system and "designed to make HIV/AIDS treatments more widely available to the poor," Reuters reports.

12 Oct 2011

Vitamin D plays an essential role in the body's fight against TB

Not just important for building strong bones, an international team of scientists has found that vitamin D also plays an essential role in the body's fight against infections such as tuberculosis.

12 Oct 2011

U.S. donates record $56M to WFP for nutrition programs in Ethiopia

The U.S. has pledged a record $56 million donation from PEPFAR to the U.N. World Food Programme (WFP) aimed to "dramatically increase resources for programs in Ethiopia providing vital nutrition assistance to people living with HIV (PLHIV)," according to a WFP press release.

12 Oct 2011

UNAIDS delegation to Russian Federation visits specialized AIDS clinic, plays in charity soccer match

"On the first of a four-day mission to the Russian Federation, UNAIDS Executive Director Michel Sidibe and UNAIDS Goodwill Ambassador James Chau visited a specialized HIV clinic near Saint Petersburg that cares for children who have been orphaned by AIDS and pregnant women living with HIV," according to a UNAIDS feature story.

12 Oct 2011

Preliminary analysis suggests $258M HIV/AIDS prevention program in India may have prevented some 100,000 infections

A $258 million HIV/AIDS prevention program in six Indian states may have prevented an estimated 100,000 infections from 2003 to 2008, researchers from the Public Health Foundation of India and the University of Washington suggest in a study published in the Lancet on Tuesday, the Associated Press/Washington Post reports.

12 Oct 2011

HIV/AIDS News and Research

Further Reading

Forum focuses on challenges facing women, girls affected by HIV in Eastern Europe, Central Asia

Health groups urge Secretary of U.S. Army to sustain funding for military HIV research program

Emergency grant to end U.S. AIDS drug crisis gets rejected

USAID award supports study of SILCS diaphragm plus tenofovir gel on HIV, HSV

Nature publishes Sangamo's gene correction strategy for A1AT deficiency

Merck announces results from ISENTRESS Phase III combination study on HIV-1

Insight into how powerful anti-HIV antibody grabs hold of the virus

Dual drug sneaks across the blood-brain barrier to fight HIV

InnaVirVax announces Phase I/IIa clinical trial authorization for its VAC-3S HIV vaccine

Viewpoints: 'Moneyball' and health care; Daschle on diabetes treatment; Elton John and Sen. Nelson on paying for AIDS drugs

Hydromorphone can be as effective as diacetylmorphine in treating heroin addiction

Mental health services are 'critical' to comprehensive approach for people living with HIV

U.S. Ambassador advises Kenya to seek additional sources of funding for health programs

VOA News examines how a public-private partnership will combat cancer among women in the developing world

Smoking could cause 18M more cases of TB worldwide over next 40 years

India's Aurobindo Pharma first major generic drugmaker to Join UNITAID's Medicines Patent Pool

Vitamin D plays an essential role in the body's fight against TB

U.S. donates record $56M to WFP for nutrition programs in Ethiopia

UNAIDS delegation to Russian Federation visits specialized AIDS clinic, plays in charity soccer match

Preliminary analysis suggests $258M HIV/AIDS prevention program in India may have prevented some 100,000 infections

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News